Dimension Therapeutics Fund Predictions

NASDAQ Stock Exchange

Open Broker Account

$5.95

+0 (+0%)

At Close: Jan 16, 2018

Currently predicting for Mon, 6 May 2024

DMTX Predictions History

BE THE FIRST TO PREDICT

The excellent way of becoming a better trader

Easy to use
Enhance your skills
Predict as many as you like
Request predictions
Gather points

Learn to time your buy and sells

I wonder how good you are and if you can beat me?

Now it is your turn to become professional by doing what professionals do - Exercise

Best regards,

Jim - Co-founder of StockInvest.us [ See tutorial video ]

About Dimension Therapeutics

Dimension Therapeutics, Inc., a gene therapy platform company, focuses on discovering and developing therapeutic products for people living with rare diseases associated with the liver and caused by genetic mutations. The company's pipeline of programs includes DTX101, a lead gene therapy product candidate designed to deliver Factor IX, gene expression in patients with hemophilia B; DTX201, a gene therapy program for the treatment of hemophilia A... DMTX Profile

Golden Star

Ticker	Date	Change	Price
CVBF	May 01	2.75%	$16.75
FTSL	May 01	0.282%	$46.03
EQC	Apr 30	0.694%	$18.72
HRB	Apr 30	0.635%	$47.23
BSCQ	Apr 30	0.576%	$19.09
BSJP	Apr 29	0.306%	$22.91
LYG	Apr 29	1.56%	$2.56
ORA	Apr 29	4.68%	$64.48
DHT	Apr 24	3.10%	$11.28
LPLA	Apr 19	3.12%	$262.59

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In